Issue Date: February 24, 2014
Implantable Metal-Filled Particles Activate Cancer Drug
Chemotherapy drugs don’t attack just malignant cells—a long-standing problem in cancer treatment. As they flow through the bloodstream, the drugs also kill healthy cells and cause debilitating side effects such as hair loss, fatigue, and nausea.
Researchers at the University of Edinburgh, in Scotland, want to reduce these adverse reactions by modifying chemotherapeutics so that the compounds become toxic only when they reach tumors. The team, led by Asier Unciti-Broceta, proposes adding . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society